Patents by Inventor Justin D. Lathia

Justin D. Lathia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer treatment using CX26 blocking peptides
    Patent number: 11136368
    Abstract: Blocking peptides that inhibit FAK or NANOG binding to Cx26, and a method of treating cancer by administering these blocking peptides to a subject in need thereof are described.
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: October 5, 2021
    Assignee: THE CLEVELAND CLINIC FOUNDATION
    Inventors: Justin D. Lathia, Ofer Reizes
  • CANCER TREATMENT
    Publication number: 20200121703
    Abstract: Provided herein are compositions, systems, kits, and methods for treating cancer by administering to a subject an agent that inhibits a target mRNA or target protein selected from ROR2, JNK1, LCK, LIME, BRCA1, and MLH1. In certain embodiments, the cancer is a uterine or ovarian cancer. In some embodiments, the cancer is chemotherapy refractory cancer (e.g., Cisplatin resistant cancer). In particular embodiments, the subject is further administered an anti-cancer agent (e.g., the agent sensitizes the cancer cells to treatment with an anti-cancer agent, such as Cisplatin).
    Type: Application
    Filed: June 26, 2018
    Publication date: April 23, 2020
    Inventors: Ofer Reizes, Justin D. Lathia
  • CANCER TREATMENT USING CX26 BLOCKING PEPTIDES
    Publication number: 20190352367
    Abstract: Blocking peptides that inhibit FAK or NANOG binding to Cx26, and a method of treating cancer by administering these blocking peptides to a subject in need thereof are described.
    Type: Application
    Filed: August 23, 2017
    Publication date: November 21, 2019
    Inventors: Justin D. Lathia, Ofer Reizes